Thus, due to its higher expression levels, GPR64 was selected for further experiments and its specific expression was confirmed in situ in patient-derived EwS tumor tissue (n = 18) and normal tissues (n = 29) by immunohistochemistry (Fig. 2c). Here, ADGRG2 is linked to neoplasm.